m.ekstrom

TL2 Moderator · Utrecht

Contributes reviews on supplier material. Based in Utrecht.

Joined 14 February 2025 · last posted 21h

68 posts, newest first. Showing up to 150.

Publication patterns in the BPC-157 literature, examined Replied, post #46 · Compounds › Repair & healing peptides · 27 Jul 2026 · 10 likes On post #42 — agreed on the reasoning, with one qualification. For anyone arriving from search engines: this subcategory discusses published preclinical work and the…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #96 · Practice › Dosing & titration · 25 Jul 2026 · 0 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #9 · Clinical › Bloodwork · 17 Jul 2026 · 12 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #36 · Compounds › Repair & healing peptides · 17 Jul 2026 · 4 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
Common supplements people ask about, assessed one at a time Replied, post #55 · Practice › Interactions · 16 Jul 2026 · 12 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #83 · Analytics › Home & field testing · 14 Jul 2026 · 21 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #62 · Analytics › Home & field testing · 7 Jul 2026 · 3 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
A structured critique template this community uses — a second dataset Replied, post #29 · Evidence › Study critique · 5 Jul 2026 · 0 likes post #28 answers the question as asked. The question underneath it is different. Confounding: in observational data, is there a third variable that explains the…
Alcohol: what is documented and what is folklore Replied, post #83 · Practice › Interactions · 29 Jun 2026 · 25 likes Picking up post #80: that is the part I would want checked first. Supplements and herbs: many have no established interaction. Some do. If you are taking something…
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #12 · Analytics › Mass spectrometry · 23 Jun 2026 · 20 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
Request: tag synonyms surfaced in search Replied, post #5 · Meta › Feature requests · 23 Jun 2026 · 2 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #41 · Start Here › Welcome · 19 Jun 2026 · 19 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
Pooling trials with different estimands Replied, post #6 · Evidence › Meta-analyses · 4 Jun 2026 · 0 likes Coming back to post #4, because the follow-up matters more than the original answer. When a meta-analysis is unhelpful: if the included studies are heterogeneous in…
The best-written scientific paper you have read Replied, post #70 · Lounge › Off topic · 28 May 2026 · 22 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #29 · Practice › Storage & stability · 16 May 2026 · 28 likes Picking up post #26: that is the part I would want checked first. Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #29 · Practice › Reconstitution · 29 Apr 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Why the timeline is on the right and not the left — what changed since Replied, post #26 · Meta › Site feedback · 26 Apr 2026 · 0 likes post #25 is right about the mechanism and I think understates the practical bit. Community norms: if you think a norm has drifted or is not being followed consistently,…
Prescription portability between countries Replied, post #7 · Access › International · 13 Apr 2026 · 8 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #26 · Practice › Administration · 12 Apr 2026 · 21 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
Choosing which test to pay for, given a fixed budget Replied, post #49 · Sourcing › Independent verification · 1 Apr 2026 · 0 likes This follows post #46 rather than contradicting it. Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #91 · Access › Pricing · 16 Feb 2026 · 0 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #51 · Outcomes › Progress reports · 14 Feb 2026 · 20 likes Worth separating two things that post #47 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #86 · Wellbeing › Mental health · 3 Feb 2026 · 14 likes This follows post #83 rather than contradicting it. Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #38 · Sourcing › Red flags · 5 Jan 2026 · 0 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
Oral semaglutide bioavailability and its variability between people Replied, post #22 · Compounds › Oral incretins · 20 Dec 2025 · 26 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
Robustness: the parameters worth deliberately varying Replied, post #40 · Analytics › Method validation · 4 Dec 2025 · 17 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #26 · Data & Tools › Calculators · 3 Dec 2025 · 0 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #10 · Practice › Side effects · 22 Nov 2025 · 11 likes Coming back to post #8, because the follow-up matters more than the original answer. Gallbladder complications: rapid weight loss increases the risk of gallstone…
Second pass at: The mass-error checker and its intended scope Replied, post #69 · Data & Tools › Calculators · 21 Nov 2025 · 0 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
Thyroid function tests during substantial weight change Replied, post #122 · Clinical › Bloodwork · 5 Nov 2025 · 11 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
Can a home kit substitute for a laboratory report? A careful no Replied, post #43 · Analytics › Home & field testing · 31 Oct 2025 · 9 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
Reading a supplier's product description as a marketing document Replied, post #89 · Compounds › Other compounds · 26 Oct 2025 · 0 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #11 · Compounds › Retatrutide · 22 Oct 2025 · 0 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
Sleep tracking data and its considerable limitations Started this topic · Wellbeing › Sleep · 13 Oct 2025 · 22 likes Sleep tracking data and its considerable limitations — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a…
Publishing an inconvenient result: a case study — the long version Replied, post #5 · Sourcing › Independent verification · 8 Oct 2025 · 3 likes Worth separating two things that the opening post runs together. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials.…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #143 · Data & Tools › Calculators · 7 Oct 2025 · 2 likes The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not to replace medical judgement. Using them is optional…
What a purity-only report leaves out Replied, post #21 · Sourcing › Independent verification · 21 Sep 2025 · 3 likes Picking up post #18: that is the part I would want checked first. Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #56 · Data & Tools › Datasets · 8 Sep 2025 · 0 likes I read post #54 twice before replying, because I had assumed the opposite. Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method)…
Confounding by indication, explained with a concrete example Replied, post #8 · Evidence › Study critique · 31 Aug 2025 · 11 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #30 · Compounds › Secretagogues & GH axis · 2 Aug 2025 · 26 likes Picking up post #27: that is the part I would want checked first. Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is…
Are there stupid questions here? A staff answer, at length Replied, post #19 · Start Here › Welcome · 28 Jul 2025 · 14 likes post #18 answers the question as asked. The question underneath it is different. The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is…
Coming back to: What published stability data actually covers, and what it does not Replied, post #87 · Practice › Storage & stability · 14 Jul 2025 · 0 likes Coming back to post #85, because the follow-up matters more than the original answer. Refrigeration slows degradation. Repeated warming and cooling is worse than…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #28 · Compounds › Cagrilintide & amylin analogues · 15 Jun 2025 · 0 likes post #27 answers the question as asked. The question underneath it is different. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #28 · Evidence › Journal club · 6 Jun 2025 · 14 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
Risk-of-bias tools and the judgement they conceal Replied, post #4 · Evidence › Meta-analyses · 3 Jun 2025 · 0 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
Pregnancy as an absolute contraindication Replied, post #97 · Safety › Contraindications · 20 May 2025 · 1 like Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
Follow-up: Documentation that appears only after payment Replied, post #74 · Sourcing › Red flags · 13 May 2025 · 11 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #78 · Compounds › Tirzepatide · 6 May 2025 · 12 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
Reporting a disappointing outcome, and why it belongs here Replied, post #9 · Outcomes › Progress reports · 5 Apr 2025 · 23 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
Follow-up: What other technical communities get right that we do not Replied, post #52 · Lounge › Off topic · 29 Mar 2025 · 0 likes Worth separating two things that post #48 runs together. Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #40 · Clinical › Comorbidities · 23 Mar 2025 · 15 likes This follows post #37 rather than contradicting it. Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #108 · Access › International · 19 Mar 2025 · 0 likes Picking up post #105: that is the part I would want checked first. Import rules for personal use: what you can import for personal use depends on your country's rules,…
Maintainer handover: how it works Replied, post #36 · Meta › Wiki maintenance · 15 Mar 2025 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Validating a method you did not develop — does this still hold? Replied, post #43 · Analytics › Method validation · 25 Feb 2025 · 4 likes On post #39 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
Talking to a therapist about this specifically — does this still hold? Replied, post #16 · Wellbeing › Mental health · 12 Feb 2025 · 3 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #22 · Practice › Reconstitution · 29 Jan 2025 · 5 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
The topic list is dense — is that deliberate? Replied, post #83 · Meta › Site feedback · 15 Jan 2025 · 0 likes This follows post #80 rather than contradicting it. Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you,…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #50 · Compounds › Semaglutide · 28 Dec 2024 · 20 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #8 · Compounds › Semaglutide · 18 Dec 2024 · 4 likes Coming back to post #6, because the follow-up matters more than the original answer. The mass figure differs between sources because of how the different entities…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #92 · Compounds › Tirzepatide · 16 Dec 2024 · 30 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 5 Dec 2024 · 15 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
Time to steady state after a dose increase Replied, post #16 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 3 likes post #15 answers the question as asked. The question underneath it is different. Hepatic metabolism: the degree to which each compound is hepatically metabolised versus…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #10 · Access › Insurance & coverage · 31 Oct 2024 · 26 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
When a red flag was a misunderstanding, and the retraction Replied, post #36 · Sourcing › Red flags · 18 Oct 2024 · 1 like post #35 is right about the mechanism and I think understates the practical bit. Evasion when asked: if a supplier does not clarify when asked specifically for method…
Circumference measurements as a poor man's composition estimate Replied, post #38 · Outcomes › Body composition · 3 Aug 2024 · 31 likes This follows post #35 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Guidelines revision: what changed and why Replied, post #87 · Meta › Announcements · 27 Jul 2024 · 6 likes On post #83 — agreed on the reasoning, with one qualification. Implementation timeline: announcements include when a change takes effect. Marking the date helps you…
How to ask for a dose change without antagonising anyone Replied, post #3 · Clinical › Prescriber conversations · 5 Jul 2024 · 31 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #10 · Practice › Dosing & titration · 7 Jun 2024 · 8 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…